Abstract
Thirteen children with hyperkalaemia were treated by intravenous infusions of salbutamol, 4 micrograms/kg over 20 minutes. Reductions in the mean (SD) plasma potassium concentrations, of 1.48 (0.5) and 1.64 (0.5) mmol/l were obtained at 40 and 120 minutes, respectively, after completion of the infusions. No side effects were noted.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blumberg A., Weidmann P., Shaw S., Gnädinger M. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med. 1988 Oct;85(4):507–512. doi: 10.1016/s0002-9343(88)80086-x. [DOI] [PubMed] [Google Scholar]
- Lens X. M., Montoliu J., Cases A., Campistol J. M., Revert L. Treatment of hyperkalaemia in renal failure: salbutamol v. insulin. Nephrol Dial Transplant. 1989;4(3):228–232. doi: 10.1093/oxfordjournals.ndt.a091860. [DOI] [PubMed] [Google Scholar]
- Smith S. R., Kendall M. J. Inhaled bronchodilators and hypokalaemia. Lancet. 1983 Jul 23;2(8343):218–218. doi: 10.1016/s0140-6736(83)90197-6. [DOI] [PubMed] [Google Scholar]
- Stemmer C. L., Perez G. O., Oster J. R. Impairment of beta 2-adrenoceptor-stimulated potassium uptake in end-stage renal disease. J Clin Pharmacol. 1987 Aug;27(8):628–631. doi: 10.1002/j.1552-4604.1987.tb03077.x. [DOI] [PubMed] [Google Scholar]
- Wang P., Clausen T. Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol. Lancet. 1976 Jan 31;1(7953):221–223. doi: 10.1016/s0140-6736(76)91340-4. [DOI] [PubMed] [Google Scholar]